Schizophrenia omega 3 fatty acid: NICE medicine-related evidence summary

NICE has published the following medicine related – ‘Evidence summary’
–  Unlicensed/off-label medicines – Schizophrenia: omega-3 fatty acid medicines  (ESUOM19)
Summary:  The randomised controlled trial (RCT) evidence for using omega-3 fatty acid medicines in people with schizophrenia is limited and the results are not consistent.

Details: http://www.nice.org.uk/mpc/evidencesummariesunlicensedofflabelmedicines/ESUOM19.jsp